Differences and similarities between ankylosing spondylitis and rheumatoid arthritis: Epidemiology

Clinical and Experimental Rheumatology

Volumn 27, Issue 4 SUPPL. 55, 2009, Pages

  Cross, Marita J ^a   Smith, Emma U R ^a   Zochling, Jane ^b   March, Lyn M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Ankylosing spondylitis; Epidemiology; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; SEX HORMONE; TUMOR NECROSIS FACTOR INHIBITOR;

ANAMNESIS; ANKYLOSING SPONDYLITIS; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CLINICAL FEATURE; DIET; DISABILITY; EUROPE; GEOGRAPHIC DISTRIBUTION; HEREDITY; HUMAN; INCIDENCE; MORTALITY; NORTH AMERICA; OBESITY; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGE OF ONSET; AGED; ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; EMPLOYMENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GEOGRAPHY; HUMANS; INCIDENCE; MALE; PREVALENCE; SEX FACTORS; SPONDYLITIS, ANKYLOSING; SURVIVAL RATE; YOUNG ADULT;

EID: 71249123153     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. SYMMONS D, MATHERS C, PFLEGER B, WORLD HEALTH ORGANISATION: The global burden of rheumatoid arthritis in the year 2000. Available from http://www3.who.int/whosis/menu.cfm?path=evidence,burden,burden- gbd2000docs&language=english;2006. Accessed 6 July 2009.
2. SIEPER J, RUDWALEIT M, KHAN MA, BRAUN J: Concepts and epidemiology of spondyloarthritis. Baillieres Best Pract Res Clin Rheumatol 2006; 20: 401-417
3. ALAMANOS Y, VOULGARI PV, DROSOS AA: Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006; 36: 182-8.
4. ALEXEEVA L, KRYLOV M, VTURIN V, MYLOV N, ERDESZ S, BENEVOLENSKAYA L: Prevalence of spondyloarthropathies and HLA-B27 in the native population of Chukotka, Russia. J Rheumatol 1994; 21: 2298-300.
5. BRAUN J, BOLLOW M, REMLINGER G et al.: Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41: 58-67.
6. GRAN JT, HUSBY G, HORDVIK M: Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromso, northern Norway. Ann Rheum Dis 1985; 44: 359-367
7. JOHNSEN K, GRAN JT, DALE K, HUSBY G: The prevalence of ankylosing spondylitis among Norwegian Samis (Lapps). J Rheumatol 1992; 19: 1591-1594
8. JULKUNEN H, KORPI J: Ankylosing spondylitis in three Finnish population samples. Prostatovesiculitis and salpingo-oophoritis as aetiological factors. Scand J Rheumatol 1983; 12 (Suppl. 52): 16-18
9. KAIPIAINEN-SEPPANEN O, AHO K, HELIOVAARA M: Incidence and prevalence of ankylosing spondylitis in Finland. J Rheumatol 1997; 24: 496-499 (Pubitemid 27153414)
10. OLIVIERI I, BAROZZI L, PADULA A, DEMATTEIS M, PAVLICA P: Clinical manifestations of seronegative spondylarthropathies. Eur J Radiol 1998; 27 (Suppl. 1): S3-6.
11. SALAFFI F, DE ANGELIS R, GRASSI W et al.: Prevalence of musculoskeletal conditions in an Italian population sample: Results of a regional community-based study. 1. The MAPPING study. Clin Exp Rheumatol 2005; 23: 819-828
12. BAKLAND G, NOSSENT HC, GRAN JT: Incidence and prevalence of ankylosing spondylitis in Northern Norway. Arthritis Rheum 2005; 53: 850-855
13. GABRIEL SE, CROWSON CS, O'FALLON WM: The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis & Rheumatism 1999; 42: 415-420
14. SPECTOR TD, HART DJ, POWELL RJ: Prevalence of rheumatoid arthritis and rheumatoid factor in women: Evidence for a secular decline. Ann Rheum Dis 1993; 52: 254-257
15. SYMMONS D, TURNER G, WEBB R et al.: The prevalence of rheumatoid arthritis in the United Kingdom: New estimates for a new century. Rheumatology 2002; 41: 793-800.
16. JACOBSSON LT, HANSON RL, KNOWLER WC et al.: Decreasing incidence and prevalence of rheumatoid arthritis in Pima Indians over a twenty-five-year period. Arthritis Rheum 1994; 37: 1158-1165
17. TOIVANEN A, TOIVANEN P: Epidemiologic aspects, clinical features, and management of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol 1994; 6: 354-9.
18. CARBONE LD, COOPER C, MICHET CJ, ATKINSON EJ, O'FALLON WM, MELTON LJ. 3RD: Ankylosing spondylitis in Rochester, Minnesota, 1935-1989. Is the epidemiology changing? Arthritis Rheum 1992; 35: 1476-82.
19. DORAN MF, POND GR, CROWSON CS, O'FALLON WM, GABRIEL SE: Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002; 46: 625-631
20. KAIPIAINEN-SEPPANEN O, KAUTIAINEN H: Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980-2000. J Rheumatol 2006; 33: 2132-2138
21. SHICHIKAWA K, INOUE K, HIROTA S et al.: Changes in the incidence and prevalence of rheumatoid arthritis in Kamitonda, Wakayama, Japan, 1965-1996. Ann Rheum Dis 1999; 58: 751-756
22. UHLIG T, KVIEN TK: Is rheumatoid arthritis disappearing? Ann Rheum Dis 2005; 64: 7-10.
23. KAIPIAINEN-SEPPANEN O, AHO K, ISOMAKI H, LAAKSO M: Shift in the incidence of theumatoid arthritis toward elderly patients in Finland during 1975-1990. Clin Exp Rheumatol 1996; 14: 537-542
24. SINGH G, LAWRENCE A, AGARWAL V, MISRA R, AGGARWAL A: Higher prevalence of extra-articular manifestations in ankylosing spondylitis with peripheral arthritis. J Clin Rheumatol 2008; 14: 264-266
25. OLIVIERI I, SALVARANI C, CANTINI F, CIANCIO G, PADULA A: Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset. Curr Opin Rheumatol 2001; 13: 280-284
26. TURKCAPAR N, DEMIR O, ATLI T et al.: Late onset rheumatoid arthritis: clinical and laboratory comparisons with younger onset patients. Arch Gerontol Geriatr 2006; 42: 225-231
27. RAMOS-REMUS C, SIERRA-JIMENEZ G, SKEITH K et al.: Latitude gradient influences the age of onset in rheumatoid arthritis patients. Clin Rheumatol 2007; 26: 1725-1728
28. SYMMONS DPM: Epidemiology of rheumatoid arthritis: Determinants of onset, persistence and outcome. Best Pract Res in Clin Rheumatol 2002; 16: 707-722 (Pubitemid 35460345)
29. FELDTKELLER E, BRUCKEL J, KHAN MA: Scientific contributions of ankylosing spondylitis patient advocacy groups. Curr Opin Rheumatol 2000; 12: 239-247
30. ACHUTHAN K, PORKODI R, RAMAKRISHNAN S et al.: Pattern of rheumatic diseases in south India. V. Ankylosing spondylitis. A clinical and radiological study. J Assoc Phys India 1990; 38: 774-776
31. AL-AMAYREH IA, ZAIDAT BO: Ankylosing spondylitis in Northern Jordan. Saudi Med J 2000; 21: 950-952
32. BAKLAND G: Epidemiology of ankylosing spondylitis. Norsk Epidemiologi 2008; 18: 10-13
33. BRUNNER R, KISSLING RO, AUCKENTHALER C, FORTIN J: Clinical evaluation of ankylosing spondylitis in Switzerland. Pain Physician 2002; 5: 49-56.
34. SAVOLAINEN E, KAIPIAINEN-SEPPANEN O, KROGER L, LUOSUJARVI R: Total Incidence and Distribution of Inflammatory Joint Diseases in a Defined Population: Results from the Kuopio 2000 Arthritis Survey. J Rheumatol 2003; 30: 2460-2468
35. TRONTZAS P, ANDRIANAKOS A, MIYAKIS S et al.: Seronegative spondyloarthropathies in Greece: A population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clinical Rheumatology 2005; 24: 583-589
36. CALIN A: Ankylosing spondylitis. Medicine 2006; 34: 396-400.
37. ALAMANOS Y, PAPADOPOULOS NG, VOULGARI PV, KARAKATSANIS A, SIOZOS C, DROSOS AA: Epidemiology of ankylosing spondylitis in Northwest Greece, 1983-2002. Rheumatology 2004; 43: 615-618
38. KOH WH, HOWE HS, BOEY ML: Ankylosing spondylitis in Singaporean Chinese - a clinical profile. Singapore Med J 1993; 34: 518-20.
39. LINOS A, WORTHINGTON JW, O'FALLON WM, KURLAND LT: The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol 1980; 111: 87-98.
40. LOCKSHIN MD: Sex differences in autoimmune disease. Orthop Clin North Am 2006; 37: 629-633
41. MACGREGOR AJ, SNIEDER H, RIGBY AS et al.: Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000; 43: 30-37
42. SILMAN AJ, MACGREGOR AJ, THOMSON W et al.: Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993; 32: 903-907
43. AHO K, KOSKENVUO M, TUOMINEN J, KAPRIO J: Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 1986; 13: 899-902. (Pubitemid 17203922)
44. BELLAMY N, DUFFY D, MARTIN N, MATHEWS J: Rheumatoid arthritis in twins: a study of aetiopathogenesis based on the Australian Twin Registry. Ann Rheum Dis 1992; 51: 588-593
45. ALAMANOS Y, DROSOS AA: Epidemiology of adult rheumatoid arthritis. Autoimmunity Rev 2005; 4: 130-136
46. WORDSWORTH P: Genes in the spondyloarthropathies. Rheum Dis Clin North Am 1998; 24: 845-863
47. CHOU CT: The association between genes and SpA in Asian. Current Rheumatology Reviews 2008; 4: 91-94
48. LINSSEN A, FELTKAMP TEW: B27 positive diseases versus B27 negative diseases. Ann Rheum Dis 1988; 47: 431-439
49. ADEBAJO A, DAVIS P: Rheumatic diseases in African blacks. Semin Arthritis Rheum 1994; 24: 139-153
50. CROMWELL KG, BARON SL: HLA-B27: what is its role in the development of ankylosing spondylitis? Arthritis Care Res 1990; 3: 216-221
51. REVEILLE JD: The genetic basis of ankylosing spondylitis. Curr Rheumatol Rep 2004; 6: 117-125
52. PEDERSEN OB, SVENDSEN AJ, EJSTRUP L, SKYTTHE A, HARRIS JR, JUNKER P: Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scand J Rheumatol 2008; 37: 120-126
53. PINCUS T, CALLAHAN LF: What is the natural history of rheumatoid arthritis? Rheum Dis Clin N Am 1993; 19: 123-151
54. BRAUN J, PINCUS T: Mortality, course of disease and prognosis of patients with ankylosing spondylitis. Clin Exp Rheumatol 2002; 20 (Suppl. 28): S16-22.
55. ZINK A, THIELE K, HUSCHER D et al.: Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 2006; 33: 86-90.
56. SOKKA T: Long-term outcomes of rheumatoid arthritis. Curr Opin Rheumatol 2009; 21: 284-290
57. BRENT LH: Inflammatory arthritis: an overview for primary care physicians. Postgrad Med 2009; 121: 148-162
58. SCOTT DL, STEER S: The course of established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007; 21: 943-967
59. DAGFINRUD H, KJEKEN I, MOWINCKEL P, HAGEN KB, KVIEN TK: Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions. J Rheumatol 2005; 32: 516-523
60. DERNIS-LABOUS E, MESSOW M, DOUGADOS M: Assessment of fatigue in the management of patients with ankylosing spondylitis. Rheumatology 2003; 42: 1523-1528
61. JONES SD, KOH WH, STEINER A, GARRETT SL, CALIN A: Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. J Rheumatol 1996; 23: 487-490
62. TURAN Y, DURUOZ MT, BAL S, GUVENC A, CERRAHOGLU L, GURGAN A: Assessment of fatigue in patients with ankylosing spondylitis. Rheumatol Int 2007; 27: 847-852 (Pubitemid 46906646)
63. TREHARNE GJ, LYONS AC, HALE ED, GOODCHILD CE, BOOTH DA, KITAS GD: Predictors of fatigue over 1 year among people with rheumatoid arthritis. Psychol Health Med 2008; 13: 494-504.
64. REPPING-WUTS H, UITTERHOEVE R, VAN RIEL P, VAN ACHTERBERG T: Fatigue as experienced by patients with rheumatoid arthritis (RA): a qualitative study. Int J Nurs Stud 2008; 45: 995-1002.
65. DAGFINRUD H, KJEKEN I, MOWINCKEL P et al.: Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions. J Rheumatol 2005; 32: 516-523
66. OKEN O, BATUR G, GUNDUZ R, YORGANCIOGLU RZ: Factors associated with functional disability in patients with rheumatoid arthritis. Rheumatol Int 2008; 29: 163-166
67. SOKKA T, TOLOZA S, CUTOLO M et al.: Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 2009; 11: R7.
68. BARLOW JH, WRIGHT CC, WILLIAMS B, KEAT A: Work disability among people with ankylosing spondylitis. Arthritis Rheum 2001; 45: 424-429
69. BOONEN A, CHORUS A, MIEDEMA H et al.: Withdrawal from labour force due to work disability in patients with ankylosing spondylitis. Ann Rheum Dis 2001; 60: 1033-1039
70. ALLAIRE S, WOLFE F, NIU J et al.: Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US. Arthritis Rheum 2008; 59: 474-480
71. BURTON W, MORRISON A, MACLEAN R, RUDERMAN E: Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med 2006; 56: 18-27.
72. BOONEN A: A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitis. Nat Clin Pract Rheumatol 2006; 2: 546-553
73. BOONEN A, CHORUS A, MIEDEMA H, VAN DER HEIJDE D, VAN DER TEMPEL H, VAN DER LINDEN S: Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients. Ann Rheum Dis 2001; 60: 353-358
74. BOONEN A, DE VET H, VAN DER HEIJDE D, VAN DER LINDEN S: Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review. J Rheumatol 2001; 28: 1056-1062
75. WALLENIUS M, SKOMSVOLL JF, KOLDINGSNES W et al.: Comparison of work disability and health-related quality of life between males and females with rheumatoid arthritis below the age of 45 years. Scand J Rheumatol 2009; 38: 178-183
76. SOKKA T, ABELSON B, PINCUS T: Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008; 26 (Suppl. 51): S35-61.
77. ZOCHLING J, BRAUN J: Mortality in ankylosing spondylitis. Clin Exp Rheumatol 2008; 26 (Suppl. 51): S80-4.
78. GRAHAM B, VAN PETEGHEM PK: Fractures of the spine in ankylosing spondylitis. Diagnosis, treatment, and complications. Spine 1989; 14: 803-807
79. BERND L, BLASIUS K, LUKOSCHEK M: Spinal fractures in ankylosing spondylitis. Z Orthop Ihre Grenzgeb 1992; 130: 59-63.
80. TAVIL Y: Cardiac involvement in ankylosing spondylitis. J Rheumatol Med Rehab 2007; 18: 69-72.
81. VAN DER HELM-VAN MIL AH, BREEDVELD FC, HUIZINGA TW, VAN DER HELM-VAN MIL AHM, BREEDVELD FC, HUIZINGA TWJ: Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity. Arthritis Res Ther 2006; 8: 216.
82. ZOCHLING J, BRAUN J: Remission in ankylosing spondylitis. Clin Exp Rheumatol 2006; 24 (Suppl. 43): S88-92.
83. OSTENSEN M: The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Am J Reprod Immunol 1992; 28: 235-237 (Pubitemid 23044840)
84. COSTENBADER KH, FESKANICH D, MANDL LA, KARLSON EW: Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med 2006; 119: 503.e1-9
85. SYMMONS DP, BANKHEAD CR, HARRISON BJ et al.: Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum 1997; 40: 1955-1961
86. RASHID T, EBRINGER A: Ankylosing spondylitis is linked to Klebsiella - the evidence. Clin Rheumatol 2007; 26: 858-864
87. MIJIYAWA M, ONIANKITAN O, KHAN MA: Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 2000; 12: 281-286
88. KAIPIAINEN-SEPPANEN O, AHO K: Incidence of chronic inflammatory joint diseases in Finland in 1995. J Rheumatol 2000; 27: 94-100.
89. BEASLEY RP, BENNETT PH, LIN CC: Low prevalence of rheumatoid arthritis in Chinese. Prevalence survey in a rural community. J Rheumatol Suppl 1983; 10: 11-15
90. CHOU CT, PEI L, CHANG DM, LEE CF, SCHUMACHER HR, LIANG MH: Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 1994; 21: 302-306
91. DAI SM, HAN XH, ZHAO DB, SHI YQ, LIU Y, MENG JM: Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: A COPCORD study. J Rheumatol 2003; 30: 2245-2251
92. MITSUI H, SONOZAKI H: Ankylosing spondylitis in Japan. Ryumachi 1981; 21 (Suppl.): 45-49
93. WIGLEY R, MANAHAN L, MUIRDEN KD et al.: Rheumatic disease in a Philippine village. II: a WHO-ILAR-APLAR COPCORD study, phases II and III. Rheumatol Int 1991; 11: 157-161
94. YE ZZ, ZHUANG JH, WANG X, LI JS, ZHANG LJ: Epidemiological survey on prevalence of ankylosing spondylitis in 5 992 Shenzhen inhabitants. Chin J Clin Rehab 2006 25; 10: 159-161
95. DAVATCHI F, JAMSHIDI AR, BANIHASHEMI AT et al.: WHO-ILAR COPCORD study (stage 1, urban study) in Iran. J Rheumatol 2008; 35: 1384-1390
96. ONEN F, AKAR S, BIRLIK M et al.: Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey. J Rheumatol 2008; 35: 305-309
97. LEHTINEN K: Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993; 52: 174-176
98. WESTERVELD LA, VERLAAN JJ, ONER FC: Spinal fractures in patients with ankylosing spinal disorders: a systematic review of the literature on treatment, neurological status and complications. Eur Spine J 2009; 18: 145-156
99. HELIOVAARA M, AHO K, AROMAA A, KNEKT P, REUNANEN A: Smoking and risk of rheumatoid arthritis. J Rheumatol 1993; 20: 1830-1835
100. KLARESKOG L, PADYUKOV L, ALFREDSSON L: Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 2007; 19: 49-54. (Pubitemid 44885727)
101. BROWN MA: Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology 2008; 47: 132-137
102. AWADA H, ABI-KARAM G, BADDOURA R, OKAIS J, ATTOUI S: Clinical, radiological, and laboratory findings in Lebanese spondylarthropathy patients according to HLA-B27 status. Joint, Bone, Spine: Revue du Rhumatisme 2000; 67: 194-198
103. MARDJUADI A, NASUTION AR, KUNMARTINI S, LARDY NM, SUDARSONO D, FELTKAMP TE: Clinical features of spondyloarthropathy in Chinese and native Indonesians. Clin Rheumatol 1999; 18: 442-445